Diagnostic Imaging Devices - Eastern Europe

  • Eastern Europe
  • The Diagnostic Imaging Devices market market in Eastern Europe is anticipated to achieve a revenue of US$0.84bn by 2024.
  • It is projected to exhibit a compound annual growth rate (CAGR 2024-2029) of 4.16%, leading to a market volume of US$1.03bn by 2029.
  • In terms of global comparison, the United States is expected to generate the highest revenue, amounting to US$11,930.00m in 2024.
  • In Eastern Europe, the demand for diagnostic imaging devices in the medical technology market is rapidly increasing due to advancements in healthcare infrastructure and a growing aging population.

Key regions: Germany, Japan, Netherlands, Spain, United States

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Diagnostic Imaging Devices market in Eastern Europe is experiencing significant growth due to several key factors. Customer preferences for advanced medical technology, increasing healthcare expenditure, and the rising prevalence of chronic diseases are driving the demand for diagnostic imaging devices in the region. Customer preferences in Eastern Europe are shifting towards advanced medical technology, including diagnostic imaging devices. Patients and healthcare providers are increasingly seeking accurate and efficient diagnostic tools to aid in the early detection and treatment of diseases. This preference for advanced technology is driving the demand for diagnostic imaging devices, such as MRI machines, CT scanners, and ultrasound systems. Trends in the market show a growing need for diagnostic imaging devices in Eastern Europe. The region is witnessing an increase in healthcare expenditure, which is enabling healthcare facilities to invest in advanced medical equipment. This investment is driven by the need to improve healthcare services and meet the growing demand for diagnostic imaging devices. Additionally, the rising prevalence of chronic diseases, such as cardiovascular diseases and cancer, is further fueling the demand for diagnostic imaging devices in the region. Local special circumstances in Eastern Europe also contribute to the development of the Diagnostic Imaging Devices market. The region has a growing aging population, which is more susceptible to chronic diseases that require diagnostic imaging for accurate diagnosis and treatment. This demographic trend is driving the demand for diagnostic imaging devices in Eastern Europe. Additionally, the region has a well-established healthcare infrastructure, with a network of hospitals and diagnostic centers that require advanced medical equipment to provide high-quality healthcare services. Underlying macroeconomic factors also play a role in the development of the Diagnostic Imaging Devices market in Eastern Europe. The region is experiencing economic growth, which is leading to increased healthcare expenditure. Governments and healthcare providers are allocating more resources to healthcare, including the procurement of diagnostic imaging devices. Furthermore, advancements in technology and increasing competition among manufacturers are driving down the prices of diagnostic imaging devices, making them more affordable and accessible in Eastern Europe. In conclusion, the Diagnostic Imaging Devices market in Eastern Europe is experiencing significant growth due to customer preferences for advanced medical technology, increasing healthcare expenditure, the rising prevalence of chronic diseases, local special circumstances, and underlying macroeconomic factors. The demand for diagnostic imaging devices is expected to continue to rise as the region strives to improve healthcare services and meet the growing healthcare needs of its population.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)